Moving Medicine Forward

Vincent Drouillon, Vice President of Global Central Lab Strategy and Growth at CTI, discusses how central laboratory services support clinical trials. He shares his path into laboratory medicine, explains why early collaboration and partnership are key to trial success, and outlines how global alignment and integrated lab solutions help sponsors move medicine forward.   00:36 Overview of Vincent’s...

Shakirah Bradford, Senior Director of Vendor Management and Sourcing at CTI, discusses the key relationships that support clinical research. She also shares her unconventional path into sourcing and highlights why vendor management is uniquely complex within regulated environments. Since joining CTI, Shakirah has helped shift vendor relationships from transactional to strategic, equipping teams wi...

Lynda Lee Smith, CEO of Enduring Hearts, is featured on the Moving Medicine Forward Podcast to discuss the mission and impact of the nation’s only nonprofit dedicated to funding pediatric heart transplant research. In this conversation, Lynda addresses the challenges transplant families face and how research is improving outcomes and quality of life. Listen now and consider donating to Enduring He...

What drives success at a clinical research site? Adam Roth , VP of Research Site Services, and Nick Finan , Director of Business Development and Client Management, share insights on site operations at CTI’s Clinical Research Center. They discuss feasibility, patient experience, trust based partnerships, and why operational realism is key to delivering high-quality clinical trials. Throughout the c...

Antibody drug conjugates (ADCs) are transforming cancer research — but how do they actually work, and what does it take to bring them safely to patients? In this episode of Moving Medicine Forward , we speak with scientist Lidia Blasco about the science and promise of antibody drug conjugates (ADCs) in cancer research. Lidia shares her journey from pharmacy and forensic analysis to oncology resear...

Paul Ayoub, co‑founder of Rarity PBC, joins this episode of Moving Medicine Forward to take us behind the scenes of developing sustainable, patient‑first gene therapies for rare genetic diseases. Paul explains how the guidance of influential mentors, combined with his experience in cell and gene therapy, shaped who he is and ultimately guided Rarity’s mission. This episode explores ADA‑SCID, the r...

In honor of World Kidney Day , we’re rereleasing this timely and insightful episode of Moving Medicine Forward . In this conversation, we sit down with Dr. Helio Tedesco , a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world’s largest kidney transplant programs and is now part of the CTI team . Joined by Dr. Christopher Boshkos , Senior Medical Director...

Christin Godale, Executive Director of LifeSciKY, and Savannah Doliboa, Chief Commercial Officer at CTI and LifeSciKY board member, explore how purpose built infrastructure can unlock the next generation of medical breakthroughs in our latest podcast episode. Together, they discuss why infrastructure is often the missing link in drug development, how regional collaboration fuels innovation, and wh...

What happens when patients become true partners in healthcare innovation? In this episode of Moving Medicine Forward , we speak with Dr. Karin Hehenberger , physician, scientist, transplant recipient, and Founder & President of Lyfebulb , about how lived experience can reshape chronic disease care. Diagnosed with type 1 diabetes as a teenager, Karin’s journey through medicine, biotech, and ult...

In honor of Rare Disease Day, we sat down with Tammy Black, Chief Communications Officer at the Immune Deficiency Foundation (IDF) , to discuss primary immunodeficiency (PI): a rare, lifelong condition that affects thousands of people and is frequently misdiagnosed. Tammy shares how living with a chronic illness shapes daily life and why education, advocacy, and strong community support are essent...

In honor of the International Day of Women and Girls in Science, we sit down with Megan Kamm , Head of Global Clinical Project Management at CTI, and Dr. Amanda King , nurse practitioner, PhD, and clinical researcher in oncology and rare disease. Together, they explore their career paths, early scientific inspirations, the promise of personalized medicine, and how women are driving innovation acro...

In this episode of Moving Medicine Forward, we speak with CTI Founder & CEO Tim Schroeder and Managing Director of Latin America Jaqueline Aguiar about the region’s scientific strength, evolving regulatory landscape, exceptional patient retention, and growing role in rare disease and advanced therapies. They share real‑world examples of record‑speed approvals, high‑quality data, and the cultur...

In this episode of Moving Medicine Forward , Dr. Monica Shah, Chief Medical Officer at CTI and President-Elect of the American Heart Association's Greater Washington Region Board of Directors, reflects on why Wear Red Day holds personal significance to her.  Dr. Shah shares her path through cardiology and clinical research, the American Heart Association’s community impact across the region, a...

In this episode of Moving Medicine Forward , we talk with Earnestine Walker and Ali Manson of ZERO Prostate Cancer about their mission to ensure every man—regardless of background—has access to early detection, support services, and quality care. They break down Blitz the Barriers , ZERO’s major initiative targeting disparities in the hardest‑hit communities, and share how programs like ZERO360 an...

In this episode, host Jeremy Schrand welcomes Tim Schroeder, Founder & CEO of CTI, Jaqueline Aguiar, Managing Director of APAC/LATAM, and Dr. Ludwig Baumann, Global Regulatory Strategist, for an in-depth conversation about the Asia Pacific region’s growing impact on clinical research. Together, they explore how population diversity, regulatory innovation, and advanced therapies are shaping the...

In this episode, host Jeremy Schrand welcomes Jamie Glavic, Senior Manager, Corporate Communications & Community Engagement and Program Lead of CTI Cares, and Kirsten Wellige, Associate Director, Clinical Project Coordination and Global Chair of the EU CTI Cares Committee, to discuss CTI Cares, CTI’s global employee-driven program that brings company values to life through community engagement...

We are joined by two leaders from Aminex Therapeutics, Mark Burns, President & CSO, and Jeff Judson, VP of Strategic Planning & Investor Relations, to discuss the groundbreaking development of Aminex 1501, a novel cancer therapy that is transforming oncology. This conversation dives into the science behind this innovative therapy, its distinctive funding journey, the promising clinical tri...

In this special year-end episode of Moving Medicine Forward , host Jeremy Schrand sits down with CTI’s founder and CEO Tim Schroeder and President & COO Jon Koch for an in-depth look at 2025. From strategic goals and operational breakthroughs to cultural pillars and global challenges, Tim and Jon share candid insights on what made this year transformative for CTI. They also discuss major clini...

Courtney Cordaro, Director and Therapeutic Strategy & Innovation Lead at CTI, discusses the rapidly changing landscape of hematology clinical research. She shares insights on operational excellence and innovation, demonstrating why adaptability and precision are key to success in hematology clinical trials.  01:00  Courtney shares her background and passions.  02:29  The growing need for rapid...

Recorded live at American Society of Nephrology’s Kidney Week 2025, this episode of Moving Medicine Forward features Courtney Cordaro, Director of Therapeutic Strategy at CTI, and Morgan Terry, Site Director at Eastern Nephrology Associates. Together, they discuss what drives a healthy and productive partnership between clinical research sites and CROs, the critical role of communication, and how...

In this inspiring episode of Moving Medicine Forward ,Amanda King, Senior Clinical Scientist at CTI, discusses her remarkable journey from pediatric ICU nurse practitioner to leading-edge oncology researcher. Amanda shares how personal loss fueled her passion for patient-centered careand clinical research, and how her work at the NIH and CTI is shaping the future of medicine. From the complexities...

Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, CRO professional, or simply curious about the...

Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-centered research, and the role of collaboration in...

In this episode, host Jeremy Schrand is joined by Tim Schroeder, Chairman, CEO, and Founder of CTI, and Joel White, Owner of Marketcap Consulting, for a broad discussion on the clinical research industry. Topics include recent industry developments, biotech funding challenges, leadership in clinical trials, corporate citizenship, and predictions for future innovation. 01:20 Tim shares insights on...

In this special episode, host Jeremy Schrand sits down with Jill Brinck, Executive Director of CancerFree KIDS, and Dr. Genevieve Kendall, a CancerFree KIDS grant recipient and pediatric cancer researcher at Baylor College of Medicine.  Together, they explore the power of early-stage research funding, the challenges and breakthroughs in treating childhood cancers, and the inspiring mission behind...